104 related articles for article (PubMed ID: 14609525)
1. Endothelin-1 decreases ethanolamine plasmalogen levels and evokes PAF production in brain microvessels.
Collado MP; Latorre E; Fernández I; Aragonés MD; Catalán RE
Microvasc Res; 2003 Nov; 66(3):197-203. PubMed ID: 14609525
[TBL] [Abstract][Full Text] [Related]
2. Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide.
Latorre E; Collado MP; Fernández I; Aragonés MD; Catalán RE
Eur J Biochem; 2003 Jan; 270(1):36-46. PubMed ID: 12492473
[TBL] [Abstract][Full Text] [Related]
3. Endothelin stimulates phosphoinositide hydrolysis and PAF synthesis in brain microvessels.
Catalán RE; Martínez AM; Aragonés MD; Martínez A; Díaz G
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1325-34. PubMed ID: 8898708
[TBL] [Abstract][Full Text] [Related]
4. Characterization of plasmalogen-selective phospholipase A2 from bovine brain.
Yang HC; Farooqui AA; Horrocks LA
Adv Exp Med Biol; 1996; 416():309-13. PubMed ID: 9131165
[TBL] [Abstract][Full Text] [Related]
5. Brain microvessel endothelin type A receptors are coupled to ceramide production.
Collado MP; Latorre E; Fernández I; Aragonés MD; Catalán RE
Biochem Biophys Res Commun; 2003 Jun; 306(1):282-5. PubMed ID: 12788101
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2).
McHowat J; Kell PJ; O'Neill HB; Creer MH
Biochemistry; 2001 Dec; 40(49):14921-31. PubMed ID: 11732912
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein.
Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P
Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379
[TBL] [Abstract][Full Text] [Related]
8. Metabolic processing of PAF.
Snyder F
Clin Rev Allergy; 1994; 12(4):309-27. PubMed ID: 7743460
[No Abstract] [Full Text] [Related]
9. Changes in glycerophospholipid profile in experimental nephrotic syndrome.
Mimura K; Zhao B; Muguruma K; Frenkel RA; Johnston JM
Metabolism; 1996 Jul; 45(7):822-6. PubMed ID: 8692015
[TBL] [Abstract][Full Text] [Related]
10. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
[TBL] [Abstract][Full Text] [Related]
11. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.
Farooqui AA; Rapoport SI; Horrocks LA
Neurochem Res; 1997 Apr; 22(4):523-7. PubMed ID: 9130265
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogens and platelet-activating factor roles in chronic inflammatory diseases.
Tremblay MÈ; Almsherqi ZA; Deng Y
Biofactors; 2022 Nov; 48(6):1203-1216. PubMed ID: 36370412
[TBL] [Abstract][Full Text] [Related]
13. THE MAGNESIUM-ION-DEPENDENT CLEAVAGE OF THE VINYL ETHER LINKAGE OF BRAIN ETHANOLAMINE PLASMALOGEN.
ANSELL GB; SPANNER S
Biochem J; 1965 Jan; 94(1):252-8. PubMed ID: 14342238
[TBL] [Abstract][Full Text] [Related]
14. Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells.
Brailoiu E; Barlow CL; Ramirez SH; Abood ME; Brailoiu GC
Neuroscience; 2018 May; 377():105-113. PubMed ID: 29522856
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation.
Slomiany BL; Slomiany A
Inflammopharmacology; 2006 Aug; 14(3-4):144-9. PubMed ID: 16983494
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects.
Deng Y; Fang W; Li Y; Cen J; Fang F; Lv P; Gong S; Mao L
Eur J Pharmacol; 2009 Aug; 616(1-3):43-7. PubMed ID: 19555682
[TBL] [Abstract][Full Text] [Related]
17. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA
Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900
[TBL] [Abstract][Full Text] [Related]
18. Purification of plasmalogens using Rhizopus delemar lipase and Naja naja naja phospholipase A2.
Hirashima Y; Farooqui AA; Murphy EJ; Horrocks LA
Lipids; 1990 Jun; 25(6):344-8. PubMed ID: 2366631
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor enhanced the pressor response of endothelin-1.
Leung SW; Man GS; Man RY
J Cardiovasc Pharmacol; 2002 Oct; 40(4):528-32. PubMed ID: 12352314
[TBL] [Abstract][Full Text] [Related]
20. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
